| Authors: |
Kaeser SA; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Schultz SA; Department of Neurology, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital, Boston, MA, USA., Hofmann A; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Häsler LM; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Xu Y; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Lambert M; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Obermüller U; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Brockmann K; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Bijzet J; Department of Laboratory Medicine, Groningen Amyloidosis Center of Expertise Groningen, University Medical Center Groningen, Groningen, the Netherlands., Nienhuis H; Department of Internal Medicine, Groningen Amyloidosis Center of Expertise, University Medical Centre Groningen, Groningen, the Netherlands. h.l.a.nienhuis@umcg.nl., Nuvolone M; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Amyloidosis Research and Treatment Center, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy., Obici L; Amyloidosis Research and Treatment Center, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy., Palladini G; Department of Molecular Medicine, University of Pavia, Pavia, Italy. giovanni.palladini@unipv.it.; Amyloidosis Research and Treatment Center, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy. giovanni.palladini@unipv.it., Hegenbart U; Amyloidosis Center, Medical Department V, University Hospital Heidelberg, Heidelberg, Germany., Schönland SO; Amyloidosis Center, Medical Department V, University Hospital Heidelberg, Heidelberg, Germany. stefan.schoenland@med.uni-heidelberg.de., Jucker M; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. mathias.jucker@uni-tuebingen.de.; Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. mathias.jucker@uni-tuebingen.de. |
